Globus Medical (GMED) Return on Capital Employed (2012 - 2026)

Globus Medical's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 10.91% for Q1 2026.

• Quarterly Return on Capital Employed rose 536.0% year-over-year to 10.91% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.91% (up 536.0% YoY) and the FY2025 annual result came in at 10.04%, up 619.0% from the prior year.
• Return on Capital Employed was 10.91% for Q1 2026 at Globus Medical, up from 10.21% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 12.23% in Q1 2023 and bottomed at 1.63% in Q2 2024.
• A 5-year average of 7.38% and a median of 8.13% in 2025 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2024 — Return on Capital Employed sank 1023 bps — and 2025, when it soared 636 bps.
• Globus Medical's Return on Capital Employed stood at 12.21% in 2022, then tumbled by 77 bps to 2.76% in 2023, then jumped by 40 bps to 3.85% in 2024, then jumped by 165 bps to 10.21% in 2025, then climbed by 7 bps to 10.91% in 2026.
• Business Quant data shows GMED's Return on Capital Employed at 10.91% in Q1 2026, 10.21% in Q4 2025, and 8.13% in Q3 2025.